Raylene M. Rospond

1.3k total citations
22 papers, 951 citations indexed

About

Raylene M. Rospond is a scholar working on Geriatrics and Gerontology, Public Health, Environmental and Occupational Health and General Health Professions. According to data from OpenAlex, Raylene M. Rospond has authored 22 papers receiving a total of 951 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Geriatrics and Gerontology, 6 papers in Public Health, Environmental and Occupational Health and 4 papers in General Health Professions. Recurrent topics in Raylene M. Rospond's work include Pharmaceutical Practices and Patient Outcomes (10 papers), Innovations in Medical Education (6 papers) and Education and Critical Thinking Development (2 papers). Raylene M. Rospond is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (10 papers), Innovations in Medical Education (6 papers) and Education and Critical Thinking Development (2 papers). Raylene M. Rospond collaborates with scholars based in United States. Raylene M. Rospond's co-authors include Judith R. OʼFallon, Charles L. Loprinzi, John C. Michalak, Ann Marie Dose, Robert A. Nelimark, Tammy Fischer, Susan K. Quella, Joseph E. Oesterling, Alan K. Hatfield and Tami L. Remington and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Clinical Pharmacokinetics.

In The Last Decade

Raylene M. Rospond

21 papers receiving 881 citations

Peers

Countries citing papers authored by Raylene M. Rospond

Since Specialization

Citations

This map shows the geographic impact of Raylene M. Rospond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raylene M. Rospond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raylene M. Rospond more than expected).

Fields of papers citing papers by Raylene M. Rospond

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raylene M. Rospond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raylene M. Rospond. The network helps show where Raylene M. Rospond may publish in the future.

Co-authorship network of co-authors of Raylene M. Rospond

This figure shows the co-authorship network connecting the top 25 collaborators of Raylene M. Rospond. A scholar is included among the top collaborators of Raylene M. Rospond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raylene M. Rospond. Raylene M. Rospond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Advancing Pharmacy Education and Workforce Development Amid the COVID-19 Pandemic: Report of the 2020-2021 AACP Academic Affairs Committee 2021 ·American Journal of Pharmaceutical Education ·(unknown), Elizabeth Blake, Brian L. Crabtree, (unknown), Amy M. Franks, Michael J. Gonyeau, Raylene M. Rospond, (unknown), (unknown), Kelly R. Ragucci	10
2	Report of the AACP Special Committee on Substance Abuse and Pharmacy Education 2010 ·American Journal of Pharmaceutical Education ·Paul W. Jungnickel, (unknown), Julie C. Kissack, (unknown), Matthew M. Murawski, Brandon J. Patterson, Raylene M. Rospond, David Scott, (unknown)	23
3	Garnering Widespread Involvement in Preparing for Accreditation Under ACPE Standards 2007 2010 ·American Journal of Pharmaceutical Education ·Charles D. Phillips, (unknown), (unknown), Raylene M. Rospond, (unknown), (unknown), (unknown), Ronald J. Torry	3
4	Variables Impacting an Academic Pharmacy Career Choice 2008 ·American Journal of Pharmaceutical Education ·(unknown), (unknown), Debbie C. Byrd, Gireesh V. Gupchup, (unknown), Miriam A. Smith, Raylene M. Rospond	33
5	Factors Influencing the Pharmacy Faculty Workforce 2008 ·American Journal of Pharmaceutical Education ·Robert S. Beardsley, Gary R. Matzke, Raylene M. Rospond, Jennifer S. Williams, Katherine K. Knapp, Wayne A. Kradjan, James P. Kehrer, (unknown), (unknown), Daniel A. Brazeau	47
6	Pharmacists and Industry: Guidelines for Ethical Interactions 2008 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·(unknown), (unknown), Mary L. Chavez, Eric W. Jackson, (unknown), Steven L. Barriere, (unknown), Ronald P. Evens, (unknown), Anne L. Hume, Lisa C. Hutchison, Gary R. Matzke, John Noviasky, Raylene M. Rospond, J S Kelloway, (unknown), (unknown), (unknown)	9
7	Essential Components of a Faculty Development Program for Pharmacy Practice Faculty 2008 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Eric G. Boyce, Jill S. Burkiewicz, (unknown), Eric J. MacLaughlin, Alissa R. Segal, Eunice Chung, Lingtak‐Neander Chan, Raylene M. Rospond, Joseph A. Barone, (unknown), Barbara G. Wells	43
8	Clinical Faculty Development 2008 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Eric G. Boyce, Jill S. Burkiewicz, (unknown), Eric J. MacLaughlin, Alissa R. Segal, Eunice Chung, Lingtak‐Neander Chan, Raylene M. Rospond, Joseph A. Barone, (unknown), Barbara G. Wells	8
9	The California Critical Thinking Instruments for Benchmarking, Program Assessment, and Directing Curricular Change 2004 ·American Journal of Pharmaceutical Education ·Charles R. Phillips, (unknown), Raylene M. Rospond	0
10	The California Critical Thinking Instruments for Benchmarking, Program Assessment, and Directing Curricular Change 2004 ·American Journal of Pharmaceutical Education ·Charles R. Phillips, (unknown), Raylene M. Rospond	43
11	Patient assessment in pharmacy practice 2003 ·(unknown), Raylene M. Rospond	9
12	Collaborative Drug Therapy Management by Pharmacists—2003 2003 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·(unknown), Amy H. Schwartz, (unknown), Tami L. Remington, Susan K. Chuck, Melissa Blair, (unknown), Raylene M. Rospond, (unknown), C. Edwin Webb	182
13	Transdermal fentanyl in the management of cancer pain in ambulatory patients: An open-label pilot study 1996 ·Journal of Pain and Symptom Management ·Julie E. Hammack, James A. Mailliard, Charles L. Loprinzi, Raylene M. Rospond, Judith R. OʼFallon, Mary B. Wilwerding, Nicholas F. Reuter, John C. Michalak, (unknown), Angela W. Miser	24
14	Megestrol Acetate for the Prevention of Hot Flashes 1995 ·Obstetrical & Gynecological Survey ·Charles L. Loprinzi, John C. Michalak, Susan K. Quella, Judith R. OʼFallon, Alan K. Hatfield, Robert A. Nelimark, Ann Marie Dose, Tammy Fischer, (unknown), (unknown), (unknown), Raylene M. Rospond, Joseph E. Oesterling	6
15	Hepatic artery chemoembolization therapy for hepatic tumors 1995 ·AORN Journal ·Raylene M. Rospond, Wendy Mills	4
16	Megestrol Acetate for the Prevention of Hot Flashes 1994 ·New England Journal of Medicine ·Charles L. Loprinzi, John C. Michalak, Susan K. Quella, Judith R. OʼFallon, Alan K. Hatfield, Robert A. Nelimark, Ann Marie Dose, Tammy Fischer, (unknown), (unknown), (unknown), Raylene M. Rospond, Joseph E. Oesterling	371
17	Randomized placebo-controlled evaluation of hydrazine sulfate in patients with advanced colorectal cancer. 1994 ·Journal of Clinical Oncology ·Charles L. Loprinzi, Steven A. Kuross, Judith R. OʼFallon, Dean H. Gesme, James B. Gerstner, Raylene M. Rospond, Charles D. Cobau, Richard M. Goldberg	69
18	Aminoglycoside Forecasting in Neutropenic Patients with Cancer 1993 ·Clinical Pharmacokinetics ·(unknown), Raylene M. Rospond, Christopher J. Destache, Phillip Hall	8
19	The Safety and Effectiveness of Long‐Term Warfarin Therapy in an Anticoagulation Clinic 1989 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Henry I. Bussey, Raylene M. Rospond, (unknown), Gary M. Clark	47
20	Evaluation of Factors Associated with Stability of Anticoagulation Therapy 1989 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Raylene M. Rospond, (unknown), Gary M. Clark, Henry I. Bussey	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact